Loading...
XSWX
VBSN
Market cap401mUSD
Apr 07, Last price  
145.00CHF
1D
-4.61%
1Q
-1.36%
Jan 2017
-28.47%
IPO
70.49%
Name

IVF Hartmann Holding AG

Chart & Performance

D1W1MN
P/E
17.01
P/S
2.17
EPS
8.53
Div Yield, %
3.45%
Shrs. gr., 5y
0.21%
Rev. gr., 5y
2.85%
Revenues
159m
+7.33%
113,614,000108,354,000106,717,000103,956,000113,673,000117,608,000118,594,000125,998,000125,434,000132,939,000132,288,000134,693,000133,449,999134,049,000137,998,000172,919,000144,067,000150,649,000147,953,000158,792,000
Net income
20m
+34.02%
4,281,0004,423,0004,754,0006,188,00010,359,00012,380,00013,166,00014,815,00015,346,00015,777,00016,091,00016,447,00016,010,00014,070,00012,169,00017,825,0006,209,00011,225,00015,148,00020,302,000
CFO
20m
-39.70%
10,032,00010,397,0004,993,00012,261,00010,321,00016,317,00015,982,00015,815,00017,775,00016,771,00020,642,00018,488,00016,642,00013,444,00018,020,00030,888,000-2,511,00017,719,00033,825,00020,398,000
Dividend
Apr 25, 20245 CHF/sh

Profile

IVF Hartmann Holding AG provides medical consumer goods in Switzerland and internationally. The company offers surgical disposable instruments, blankets, clothing and gloves, disinfection and hygiene products, wound management and hydrotherapy services, incontinence management, and first aid products, as well as various courses. It serves private doctors; outpatient medicine and care; hospitals and clinics; pharmacies and drugstores; nursing homes; and medical and food retailers, as well as industrial customers. The company was formerly known as IVF and changed its name to IVF Hartmann Holding AG in 1993. The company was founded in 1874 and is headquartered in Neuhausen am Rheinfall, Switzerland.
URL
https://www.ivf.hartmann.info
IPO date
Jul 16, 2012
Employees
293
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
158,792
7.33%
147,953
-1.79%
150,649
4.57%
Cost of revenue
68,962
102,968
106,732
Unusual Expense (Income)
NOPBT
89,830
44,985
43,917
NOPBT Margin
56.57%
30.40%
29.15%
Operating Taxes
3,804
2,759
1,925
Tax Rate
4.23%
6.13%
4.38%
NOPAT
86,026
42,226
41,992
Net income
20,302
34.02%
15,148
34.95%
11,225
80.79%
Dividends
(19,680)
(6,000)
(4,560)
Dividend yield
5.47%
2.23%
1.61%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
548
487
427
Long-term debt
2,060
1,708
1,008
Deferred revenue
Other long-term liabilities
670
605
689
Net debt
(106,319)
(85,721)
(38,380)
Cash flow
Cash from operating activities
20,398
33,825
17,719
CAPEX
(2,224)
(2,420)
(2,706)
Cash from investing activities
6,220
20,437
(2,678)
Cash from financing activities
(19,680)
(6,000)
(4,560)
FCF
148,571
37,286
44,872
Balance
Cash
108,927
87,916
39,815
Long term investments
Excess cash
100,987
80,518
32,283
Stockholders' equity
144,158
151,376
143,673
Invested Capital
52,985
72,804
112,304
ROIC
136.78%
45.62%
36.70%
ROCE
57.33%
28.85%
29.75%
EV
Common stock shares outstanding
2,400
2,401
2,374
Price
150.00
33.93%
112.00
-6.28%
119.50
-2.85%
Market cap
359,965
33.88%
268,871
-5.23%
283,697
-2.85%
EV
253,646
183,150
245,317
EBITDA
95,025
50,507
50,028
EV/EBITDA
2.67
3.63
4.90
Interest
268
19
343
Interest/NOPBT
0.30%
0.04%
0.78%